Teitur Trophics
PrivateLast Round
Series A
Mar 14, 2023
Total Funding Raised
$31.33M
Momentum Score
25 /100
Company Overview
Teitur Trophics is a biotechnology company that develops first-in-class peptide-based therapies for neurodegenerative diseases such as Parkinson's and Huntington's Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teitur Trophics Comps
Public and private peers based on sector, stage, and business model.
Teitur Trophics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 14, 2023 | ||||
| Seed | Oct 1, 2020 |
Teitur Trophics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Industrifonden | Series A |
| Innovestor Life Science Fund | Series A |
| P53 Invest | Series A |
| Sunstone Life Science Ventures | Series A |
| BioInnovation Institute | Seed |
| Sound Bioventures | Series A |
Teitur Trophics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Teitur Trophics's valuation, stock price, and market status.
